$WST
WEST PHARMACEUTICAL SERVICES INC

2022 Q1 Form 10-Q Financial Statement

#000010577022000017 Filed on April 28, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q1
Revenue $720.0M $670.7M
YoY Change 7.35% 36.46%
Cost Of Revenue $435.4M $398.8M
YoY Change 9.18% 22.9%
Gross Profit $284.6M $271.9M
YoY Change 4.67% 62.81%
Gross Profit Margin 39.53% 40.54%
Selling, General & Admin $83.40M $80.20M
YoY Change 3.99% 11.7%
% of Gross Profit 29.3% 29.5%
Research & Development $14.60M $12.20M
YoY Change 19.67% 14.02%
% of Gross Profit 5.13% 4.49%
Depreciation & Amortization $28.70M $28.00M
YoY Change 2.5% 12.45%
% of Gross Profit 10.08% 10.3%
Operating Expenses $98.00M $92.40M
YoY Change 6.06% 12.0%
Operating Profit $189.7M $175.6M
YoY Change 8.03% 99.55%
Interest Expense $2.200M $1.900M
YoY Change 15.79% -5.0%
% of Operating Profit 1.16% 1.08%
Other Income/Expense, Net -$1.900M -$700.0K
YoY Change 171.43% -146.67%
Pretax Income $187.8M $174.9M
YoY Change 7.38% 102.2%
Income Tax $21.20M $28.70M
% Of Pretax Income 11.29% 16.41%
Net Earnings $173.8M $151.2M
YoY Change 14.95% 103.5%
Net Earnings / Revenue 24.14% 22.54%
Basic Earnings Per Share $2.34 $2.04
Diluted Earnings Per Share $2.29 $1.99
COMMON SHARES
Basic Shares Outstanding 74.40M shares 73.90M shares
Diluted Shares Outstanding 76.00M shares 75.80M shares

Balance Sheet

Concept 2022 Q1 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $667.7M $483.7M
YoY Change 38.04% 44.26%
Cash & Equivalents $667.7M $483.7M
Short-Term Investments
Other Short-Term Assets $107.6M $67.40M
YoY Change 59.64% 15.81%
Inventory $416.5M $310.2M
Prepaid Expenses
Receivables $498.7M $465.7M
Other Receivables $0.00 $0.00
Total Short-Term Assets $1.691B $1.327B
YoY Change 27.39% 35.75%
LONG-TERM ASSETS
Property, Plant & Equipment $1.066B $930.8M
YoY Change 14.51% 12.37%
Goodwill $108.8M $109.5M
YoY Change -0.64% 2.43%
Intangibles $21.80M $28.70M
YoY Change -24.04% 2.14%
Long-Term Investments $198.0M $201.3M
YoY Change -1.64% 9.22%
Other Assets $40.50M $24.80M
YoY Change 63.31% 12.73%
Total Long-Term Assets $1.604B $1.413B
YoY Change 13.56% 11.32%
TOTAL ASSETS
Total Short-Term Assets $1.691B $1.327B
Total Long-Term Assets $1.604B $1.413B
Total Assets $3.295B $2.740B
YoY Change 20.26% 21.95%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $248.2M $204.3M
YoY Change 21.49% 29.39%
Accrued Expenses $89.70M $81.70M
YoY Change 9.79% 12.23%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $44.20M $2.300M
YoY Change 1821.74% 0.0%
Total Short-Term Liabilities $584.8M $482.8M
YoY Change 21.13% 40.19%
LONG-TERM LIABILITIES
Long-Term Debt $208.3M $252.3M
YoY Change -17.44% -0.83%
Other Long-Term Liabilities $38.20M $28.30M
YoY Change 34.98% -29.25%
Total Long-Term Liabilities $246.5M $280.6M
YoY Change -12.15% -4.69%
TOTAL LIABILITIES
Total Short-Term Liabilities $584.8M $482.8M
Total Long-Term Liabilities $246.5M $280.6M
Total Liabilities $968.5M $910.7M
YoY Change 6.35% 20.42%
SHAREHOLDERS EQUITY
Retained Earnings $2.617B $1.985B
YoY Change 31.83% 23.18%
Common Stock $18.80M $18.80M
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $347.4M $281.7M
YoY Change 23.32% 30.6%
Treasury Stock Shares 1.200M shares 1.500M shares
Shareholders Equity $2.326B $1.829B
YoY Change
Total Liabilities & Shareholders Equity $3.295B $2.740B
YoY Change 20.26% 21.95%

Cashflow Statement

Concept 2022 Q1 2021 Q1
OPERATING ACTIVITIES
Net Income $173.8M $151.2M
YoY Change 14.95% 103.5%
Depreciation, Depletion And Amortization $28.70M $28.00M
YoY Change 2.5% 12.45%
Cash From Operating Activities $151.2M $88.70M
YoY Change 70.46% 55.34%
INVESTING ACTIVITIES
Capital Expenditures $65.80M $54.70M
YoY Change 20.29% 70.4%
Acquisitions
YoY Change
Other Investing Activities $2.500M -$200.0K
YoY Change -1350.0% 0.0%
Cash From Investing Activities -$68.30M -$54.50M
YoY Change 25.32% 70.85%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $147.1M $137.1M
YoY Change 7.29% 18.7%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$172.7M -$156.4M
YoY Change 10.42% 30.01%
NET CHANGE
Cash From Operating Activities $151.2M $88.70M
Cash From Investing Activities -$68.30M -$54.50M
Cash From Financing Activities -$172.7M -$156.4M
Net Change In Cash -$94.90M -$131.8M
YoY Change -28.0% 26.97%
FREE CASH FLOW
Cash From Operating Activities $151.2M $88.70M
Capital Expenditures $65.80M $54.70M
Free Cash Flow $85.40M $34.00M
YoY Change 151.18% 36.0%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000105770
CY2022Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q1 dei Amendment Flag
AmendmentFlag
false
CY2022Q1 dei Document Type
DocumentType
10-Q
CY2022Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q1 dei Entity File Number
EntityFileNumber
1-8036
CY2022Q1 dei Entity File Number
EntityFileNumber
1-8036
CY2022Q1 dei Entity Registrant Name
EntityRegistrantName
WEST PHARMACEUTICAL SERVICES, INC.
CY2022Q1 dei Entity Registrant Name
EntityRegistrantName
WEST PHARMACEUTICAL SERVICES, INC.
CY2022Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
PA
CY2022Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
23-1210010
CY2022Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
530 Herman O. West Drive
CY2022Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Exton
CY2022Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
PA
CY2022Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
19341-0645
CY2022Q1 dei City Area Code
CityAreaCode
610
CY2022Q1 dei Local Phone Number
LocalPhoneNumber
594-2900
CY2022Q1 dei Security12b Title
Security12bTitle
Common Stock, par value $0.25 per share
CY2022Q1 dei Trading Symbol
TradingSymbol
WST
CY2022Q1 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2022Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021Q1 wst Other Income Expense
OtherIncomeExpense
-3900000 USD
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
189700000 USD
CY2022Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2022Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2022Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q1 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
74075617 shares
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
720000000.0 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
670700000 USD
CY2022Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
435400000 USD
CY2021Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
398800000 USD
CY2022Q1 us-gaap Gross Profit
GrossProfit
284600000 USD
CY2021Q1 us-gaap Gross Profit
GrossProfit
271900000 USD
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14600000 USD
CY2021Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12200000 USD
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
83400000 USD
CY2021Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
80200000 USD
CY2022Q1 wst Other Income Expense
OtherIncomeExpense
3100000 USD
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
7200000 USD
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
175600000 USD
CY2022Q1 us-gaap Interest Expense
InterestExpense
2200000 USD
CY2021Q1 us-gaap Interest Expense
InterestExpense
1900000 USD
CY2022Q1 us-gaap Investment Income Net
InvestmentIncomeNet
300000 USD
CY2021Q1 us-gaap Investment Income Net
InvestmentIncomeNet
100000 USD
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 USD
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1100000 USD
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
187800000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
174900000 USD
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
21200000 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
28700000 USD
CY2021Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
5000000.0 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
173800000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
151200000 USD
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.34
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.04
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.29
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.99
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
74400000 shares
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
73900000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
76000000.0 shares
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
75800000 shares
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
173800000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
151200000 USD
CY2022Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-22100000 USD
CY2021Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-28400000 USD
CY2022Q1 us-gaap Other Comprehensive Income Defined Benefit Plans Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent
-300000 USD
CY2021Q1 us-gaap Other Comprehensive Income Defined Benefit Plans Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent
-200000 USD
CY2022Q1 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
-900000 USD
CY2021Q1 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
-600000 USD
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent
-800000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent
-700000 USD
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
-1600000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
-1800000 USD
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-22800000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-29600000 USD
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
151000000.0 USD
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
121600000 USD
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
667700000 USD
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
762600000 USD
CY2022Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
498700000 USD
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
489000000.0 USD
CY2022Q1 us-gaap Inventory Net
InventoryNet
416500000 USD
CY2021Q4 us-gaap Inventory Net
InventoryNet
378400000 USD
CY2022Q1 us-gaap Other Assets Current
OtherAssetsCurrent
107600000 USD
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
112000000.0 USD
CY2022Q1 us-gaap Assets Current
AssetsCurrent
1690500000 USD
CY2021Q4 us-gaap Assets Current
AssetsCurrent
1742000000 USD
CY2022Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2237000000 USD
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2215000000 USD
CY2022Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1171100000 USD
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1157500000 USD
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1065900000 USD
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1057500000 USD
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
75600000 USD
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
69300000 USD
CY2022Q1 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
208100000 USD
CY2021Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
207700000 USD
CY2022Q1 us-gaap Goodwill
Goodwill
108800000 USD
CY2021Q4 us-gaap Goodwill
Goodwill
109900000 USD
CY2022Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
21800000 USD
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
23000000.0 USD
CY2022Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
66400000 USD
CY2021Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
48500000 USD
CY2022Q1 us-gaap Defined Benefit Plan Assets For Plan Benefits Noncurrent
DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
17100000 USD
CY2021Q4 us-gaap Defined Benefit Plan Assets For Plan Benefits Noncurrent
DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
16700000 USD
CY2022Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
40500000 USD
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
39200000 USD
CY2022Q1 us-gaap Assets
Assets
3294700000 USD
CY2021Q4 us-gaap Assets
Assets
3313800000 USD
CY2022Q1 wst Notes Payable And Other Debt Current
NotesPayableAndOtherDebtCurrent
44200000 USD
CY2021Q4 wst Notes Payable And Other Debt Current
NotesPayableAndOtherDebtCurrent
44200000 USD
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
248200000 USD
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
232200000 USD
CY2022Q1 us-gaap Pension And Other Postretirement Defined Benefit Plans Current Liabilities
PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
2400000 USD
CY2021Q4 us-gaap Pension And Other Postretirement Defined Benefit Plans Current Liabilities
PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
2400000 USD
CY2022Q1 wst Accrued Salaries Wages And Benefits Current
AccruedSalariesWagesAndBenefitsCurrent
77500000 USD
CY2021Q4 wst Accrued Salaries Wages And Benefits Current
AccruedSalariesWagesAndBenefitsCurrent
116300000 USD
CY2022Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
34700000 USD
CY2021Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
26300000 USD
CY2022Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
9800000 USD
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
9300000 USD
CY2022Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
168000000.0 USD
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
163400000 USD
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
584800000 USD
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
594100000 USD
CY2022Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
208300000 USD
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
208800000 USD
CY2022Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
3300000 USD
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
4900000 USD
CY2022Q1 us-gaap Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
38700000 USD
CY2021Q4 us-gaap Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
40500000 USD
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
68900000 USD
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
63000000.0 USD
CY2022Q1 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
26300000 USD
CY2021Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
28900000 USD
CY2022Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
38200000 USD
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
38200000 USD
CY2022Q1 us-gaap Liabilities
Liabilities
968500000 USD
CY2021Q4 us-gaap Liabilities
Liabilities
978400000 USD
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
3000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
3000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
5900000 USD
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.25
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.25
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
75300000 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
75300000 shares
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
74100000 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
74200000 shares
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
18800000 USD
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
18800000 USD
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
219900000 USD
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
249000000.0 USD
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
2617300000 USD
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
2456700000 USD
CY2022Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-182400000 USD
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-159600000 USD
CY2022Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
1200000 shares
CY2021Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
1100000 shares
CY2022Q1 us-gaap Treasury Stock Value
TreasuryStockValue
347400000 USD
CY2021Q4 us-gaap Treasury Stock Value
TreasuryStockValue
229500000 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
2326200000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
2335400000 USD
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3294700000 USD
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3313800000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
173800000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
151200000 USD
CY2022Q1 us-gaap Depreciation
Depreciation
28700000 USD
CY2021Q1 us-gaap Depreciation
Depreciation
28000000.0 USD
CY2022Q1 us-gaap Adjustment For Amortization
AdjustmentForAmortization
900000 USD
CY2021Q1 us-gaap Adjustment For Amortization
AdjustmentForAmortization
1100000 USD
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
5500000 USD
CY2022Q1 us-gaap Defined Benefit Plan Recognized Net Gain Loss Due To Curtailments
DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments
-600000 USD
CY2021Q1 us-gaap Defined Benefit Plan Recognized Net Gain Loss Due To Curtailments
DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments
-600000 USD
CY2022Q1 us-gaap Payment For Contingent Consideration Liability Operating Activities
PaymentForContingentConsiderationLiabilityOperatingActivities
400000 USD
CY2021Q1 us-gaap Payment For Contingent Consideration Liability Operating Activities
PaymentForContingentConsiderationLiabilityOperatingActivities
400000 USD
CY2022Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
7700000 USD
CY2021Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
2800000 USD
CY2022Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
50200000 USD
CY2021Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
94900000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
151200000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
88700000 USD
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
65800000 USD
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
54700000 USD
CY2022Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
2500000 USD
CY2021Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-200000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-68300000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-54500000 USD
CY2022Q1 us-gaap Repayments Of Other Long Term Debt
RepaymentsOfOtherLongTermDebt
600000 USD
CY2021Q1 us-gaap Repayments Of Other Long Term Debt
RepaymentsOfOtherLongTermDebt
600000 USD
CY2022Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
1100000 USD
CY2021Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 USD
CY2022Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
13400000 USD
CY2021Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
12600000 USD
CY2022Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
6300000 USD
CY2021Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
5800000 USD
CY2022Q1 us-gaap Proceeds From Other Equity
ProceedsFromOtherEquity
2000000.0 USD
CY2021Q1 us-gaap Proceeds From Other Equity
ProceedsFromOtherEquity
1800000 USD
CY2022Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
147100000 USD
CY2021Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
137100000 USD
CY2022Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
18800000 USD
CY2021Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
13700000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-172700000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-156400000 USD
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-5100000 USD
CY2021Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-9600000 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-94900000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-131800000 USD
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
762600000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
615500000 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
667700000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
483700000 USD
CY2021Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
14600000 USD
CY2022Q1 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
14800000 USD
CY2022Q1 wst Contract With Customer Asset Increase Decrease
ContractWithCustomerAssetIncreaseDecrease
200000 USD
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
61300000 USD
CY2022Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
56800000 USD
CY2022Q1 us-gaap Contract With Customer Liability Change In Timeframe Performance Obligation Satisfied Revenue Recognized
ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized
4500000 USD
CY2022Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
9700000 USD
CY2021Q4 us-gaap Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
650000 shares
CY2022Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
390000 shares
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
173800000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
151200000 USD
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
74400000 shares
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
73900000 shares
CY2022Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1600000 shares
CY2021Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1900000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
76000000.0 shares
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
75800000 shares
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2021Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
100000 shares
CY2022Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
147100000 USD
CY2022Q1 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
377.23
CY2022Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
167400000 USD
CY2021Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
153800000 USD
CY2022Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
70200000 USD
CY2021Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
63500000 USD
CY2022Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
178900000 USD
CY2021Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
161100000 USD
CY2022Q1 us-gaap Inventory Net
InventoryNet
416500000 USD
CY2021Q4 us-gaap Inventory Net
InventoryNet
378400000 USD
CY2022Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
3300000 USD
CY2021Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
3100000 USD
CY2022Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
400000 USD
CY2021Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
200000 USD
CY2022Q1 us-gaap Variable Lease Cost
VariableLeaseCost
1400000 USD
CY2021Q1 us-gaap Variable Lease Cost
VariableLeaseCost
800000 USD
CY2022Q1 us-gaap Lease Cost
LeaseCost
5100000 USD
CY2021Q1 us-gaap Lease Cost
LeaseCost
4100000 USD
CY2022Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
3200000 USD
CY2021Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
3200000 USD
CY2022Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
9700000 USD
CY2021Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
500000 USD
CY2022Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P10Y4M24D
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P10Y8M12D
CY2022Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0352
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0358
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
9300000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
11500000 USD
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
11700000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
10700000 USD
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
11100000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
10000000.0 USD
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
9400000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
8200000 USD
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
8400000 USD
CY2022Q1 wst Purchases And Royalty Payments From Equity Method Investees
PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees
58500000 USD
CY2022Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
15000000.0 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
7300000 USD
CY2022Q1 wst Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
43800000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
38700000 USD
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
93700000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
86400000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
14100000 USD
CY2022Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
78700000 USD
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
72300000 USD
CY2022Q1 us-gaap Equity Method Investments
EquityMethodInvestments
198000000 USD
CY2021Q4 us-gaap Equity Method Investments
EquityMethodInvestments
201200000 USD
CY2022Q1 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
10100000 USD
CY2021Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
6500000 USD
CY2021Q1 wst Purchases And Royalty Payments From Equity Method Investees
PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees
38000000 USD
CY2022Q1 us-gaap Due To Affiliate Current And Noncurrent
DueToAffiliateCurrentAndNoncurrent
45100000 USD
CY2021Q4 us-gaap Due To Affiliate Current And Noncurrent
DueToAffiliateCurrentAndNoncurrent
25500000 USD
CY2022Q1 wst Sales To Equity Method Investees
SalesToEquityMethodInvestees
4000000 USD
CY2021Q1 wst Sales To Equity Method Investees
SalesToEquityMethodInvestees
2900000 USD
CY2022Q1 us-gaap Due From Affiliates
DueFromAffiliates
3300000 USD
CY2021Q4 us-gaap Due From Affiliates
DueFromAffiliates
2300000 USD
CY2022Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
252900000 USD
CY2021Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
253500000 USD
CY2022Q1 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
400000 USD
CY2021Q4 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
500000 USD
CY2022Q1 us-gaap Long Term Debt
LongTermDebt
252500000 USD
CY2021Q4 us-gaap Long Term Debt
LongTermDebt
253000000.0 USD
CY2022Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
44200000 USD
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
44200000 USD
CY2022Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
208300000 USD
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
208800000 USD
CY2022Q1 us-gaap Gain Loss On Fair Value Hedges Recognized In Earnings
GainLossOnFairValueHedgesRecognizedInEarnings
-800000 USD
CY2021Q1 us-gaap Gain Loss On Fair Value Hedges Recognized In Earnings
GainLossOnFairValueHedgesRecognizedInEarnings
-600000 USD
CY2022Q1 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
15000000.0 USD
CY2022Q1 us-gaap Foreign Currency Contract Asset Fair Value Disclosure
ForeignCurrencyContractAssetFairValueDisclosure
23300000 USD
CY2022Q1 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
50900000 USD
CY2022Q1 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
4000000.0 USD
CY2022Q1 us-gaap Other Deferred Compensation Arrangements Liability Classified Noncurrent
OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent
15400000 USD
CY2022Q1 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
23900000 USD
CY2021Q4 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
15500000 USD
CY2021Q4 us-gaap Foreign Currency Contract Asset Fair Value Disclosure
ForeignCurrencyContractAssetFairValueDisclosure
14800000 USD
CY2021Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
36400000 USD
CY2021Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
3700000 USD
CY2021Q4 us-gaap Other Deferred Compensation Arrangements Liability Classified Noncurrent
OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent
16100000 USD
CY2021Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
23200000 USD
CY2022Q1 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
210400000 USD
CY2022Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
208300000 USD
CY2021Q4 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
217900000 USD
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
208800000 USD
CY2022Q1 us-gaap Oci Before Reclassifications Net Of Tax Attributable To Parent
OciBeforeReclassificationsNetOfTaxAttributableToParent
-23600000 USD
CY2022Q1 us-gaap Reclassification From Aoci Current Period Net Of Tax Attributable To Parent
ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
-800000 USD
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-22800000 USD
CY2021Q1 us-gaap Oci Before Reclassifications Net Of Tax Attributable To Parent
OciBeforeReclassificationsNetOfTaxAttributableToParent
-30900000 USD
CY2021Q1 us-gaap Reclassification From Aoci Current Period Net Of Tax Attributable To Parent
ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
-1300000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-29600000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
2335400000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
173800000 USD
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
100000 USD
CY2022Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
147100000 USD
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.18
CY2022Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
13200000 USD
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-22800000 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
2326200000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
1854500000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
151200000 USD
CY2021Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2500000 USD
CY2021Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
137100000 USD
CY2021Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.17
CY2021Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
12500000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-29600000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
1829000000 USD
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
1727432 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
109496 shares
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
369.13
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
96.50
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.018
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y7M6D
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.249
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.002
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5500000 USD
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5900000 USD
CY2022Q1 us-gaap Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
400000 USD
CY2021Q1 us-gaap Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
400000 USD
CY2022Q1 us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
1600000 USD
CY2021Q1 us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
1500000 USD
CY2022Q1 us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
2200000 USD
CY2021Q1 us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
3100000 USD
CY2022Q1 us-gaap Defined Benefit Plan Amortization Of Prior Service Cost Credit
DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
0 USD
CY2021Q1 us-gaap Defined Benefit Plan Amortization Of Prior Service Cost Credit
DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
-100000 USD
CY2022Q1 us-gaap Defined Benefit Plan Actuarial Gain Loss
DefinedBenefitPlanActuarialGainLoss
0 USD
CY2021Q1 us-gaap Defined Benefit Plan Actuarial Gain Loss
DefinedBenefitPlanActuarialGainLoss
-100000 USD
CY2022Q1 us-gaap Defined Benefit Plan Recognized Net Gain Loss Due To Settlements1
DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
-600000 USD
CY2021Q1 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
-600000 USD
CY2021Q1 us-gaap Defined Benefit Plan Recognized Net Gain Loss Due To Settlements1
DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
-600000 USD
CY2022Q1 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
400000 USD
CY2022Q1 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
400000 USD
CY2021Q1 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
-600000 USD
CY2021Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
300000 USD
CY2022Q1 us-gaap Restructuring And Related Cost Incurred Cost
RestructuringAndRelatedCostIncurredCost
0 USD
CY2021Q1 us-gaap Restructuring And Related Cost Incurred Cost
RestructuringAndRelatedCostIncurredCost
1200000 USD
CY2022Q1 us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
100000 USD
CY2021Q1 us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
-100000 USD
CY2022Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
800000 USD
CY2021Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
700000 USD
CY2022Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
1100000 USD
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
187800000 USD
CY2021Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-2200000 USD
CY2022Q1 wst Other Income Expense
OtherIncomeExpense
3100000 USD
CY2021Q1 wst Other Income Expense
OtherIncomeExpense
-3900000 USD
CY2022Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
2700000 USD
CY2021Q1 us-gaap Impairment Of Investments
ImpairmentOfInvestments
2200000 USD
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
21200000 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
28700000 USD
CY2022Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.113
CY2021Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.164
CY2022Q1 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
-8900000 USD
CY2021Q1 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
-11100000 USD
CY2022Q1 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-5900000 USD
CY2022Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
CY2022Q1 us-gaap Revenues
Revenues
720000000.0 USD
CY2021Q1 us-gaap Revenues
Revenues
670700000 USD
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
189700000 USD
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
175600000 USD
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1900000 USD
CY2021Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-700000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
174900000 USD
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
200000 USD
CY2021Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
200000 USD

Files In Submission

Name View Source Status
0000105770-22-000017-index-headers.html Edgar Link pending
0000105770-22-000017-index.html Edgar Link pending
0000105770-22-000017.txt Edgar Link pending
0000105770-22-000017-xbrl.zip Edgar Link pending
ex311q12022.htm Edgar Link pending
ex312q12022.htm Edgar Link pending
ex321q12022.htm Edgar Link pending
ex322q12022.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
wst-20220331.htm Edgar Link pending
wst-20220331.xsd Edgar Link pending
wst-20220331_cal.xml Edgar Link unprocessable
wst-20220331_def.xml Edgar Link unprocessable
wst-20220331_htm.xml Edgar Link completed
wst-20220331_lab.xml Edgar Link unprocessable
wst-20220331_pre.xml Edgar Link unprocessable